Fluorinated albumin nanoplatform for 19F MRI-guided synergistic chemo-chemodynamic therapy and immune activation in breast cancer

Developing nanomedicines from natural sources with synergistic effects to activate effective antitumor immune response remains a significant challenge. Here, we present a fluorinated bovine serum albumin (BSA)-based selfassembling nanoplatform that integrates chemotherapy (Chemo) and chemodynamic therapy (CDT) to induce immunogenic cell death (ICD) of breast cancer. This nanoplatform efficiently encapsulates doxorubicin (DOX)
and fluorine-19 magnetic resonance imaging (19F MRI)-sensitive F-oil in its core, with gallic acid (GA)-stabilized Fe3+ on its surface. Its selective accumulation at tumor sites generates persistent “hot spot” 19F MRI signals for drug tracking and tumor imaging. In the tumor microenvironment (TME), Fe3+ depletes glutathione (GSH), while DOX increases hydrogen peroxide (H2O2) levels, thereby amplifying CDT. This triggers a strong immune
response, inhibiting primary and distant tumor growth in 4T1 tumor-bearing mice. By optimizing the TME for immune-mediated tumor eradication, this nanoplatform overcomes conventional CDT and immunotherapy
limitations, highlighting fluorinated BSA as a promising platform for image-guided synergistic cancer therapy.